Profilo
Fondatore di Amicus Therapeutics, Inc., Orexigen Therapeutics, Inc. e Novazyme Pharmaceuticals, Inc., John Francis Crowley è presidente e amministratore delegato di Amicus Therapeutics, Inc. Il signor Crowley è anche nel consiglio di amministrazione di altre 6 società. In passato è stato direttore della strategia aziendale alla Bristol Myers Squibb Co, presidente e amministratore delegato della Orexigen Therapeutics, Inc, presidente e amministratore delegato della Novazyme Pharmaceuticals, Inc, Litigation Associate-Health Care Practice Group alla Bingham Summers Welsh & Spilman, vicepresidente senior della Genzyme Therapeutics Ltd. e presidente nazionale della Make-A-Wish Foundation of America. Ha conseguito una laurea presso la Georgetown University, una laurea presso la University of Notre Dame The Law School e un MBA presso la Harvard Business School.
Posizioni attive di John Crowley
| Società | Posizione | Inizio |
|---|---|---|
St. Peter's University Hospital
St. Peter's University Hospital Medical/Nursing ServicesHealth Services Provides healthcare services | Direttore/Membro del Consiglio | 23/11/2010 |
Scioderm, Inc.
Scioderm, Inc. BiotechnologyHealth Technology Engages in the development of innovative therapies for areas of high unmet need, including orphan products | Presidente | - |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
Global Genes
Global Genes Miscellaneous Commercial ServicesCommercial Services Operates organization for promoting rare diseases and advocacy services | Direttore/Membro del Consiglio | - |
The Wall Street Journal CEO Council | Corporate Officer/Principal | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Amministratore Delegato | 04/03/2024 |
Precedenti posizioni note di John Crowley
| Società | Posizione | Fine |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Amministratore Delegato | 01/08/2022 |
| ENTRADA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 05/12/2023 |
| INTELLIA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 05/12/2023 |
| ░░░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di John Crowley
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 19 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Scioderm, Inc.
Scioderm, Inc. BiotechnologyHealth Technology Engages in the development of innovative therapies for areas of high unmet need, including orphan products | Health Technology |
Bingham Summers Welsh & Spilman
Bingham Summers Welsh & Spilman Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Novazyme Pharmaceuticals, Inc.
Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops methods for modifying recombinantly produced enzymes | Commercial Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Make-A-Wish Foundation of America
Make-A-Wish Foundation of America Miscellaneous Commercial ServicesCommercial Services Operates as a charitable organization | Commercial Services |
St. Peter's University Hospital
St. Peter's University Hospital Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
The Wall Street Journal CEO Council | |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Notre Dame The Law School
University of Notre Dame The Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Global Genes
Global Genes Miscellaneous Commercial ServicesCommercial Services Operates organization for promoting rare diseases and advocacy services | Commercial Services |
Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
















